A new study shows young adults with higher exposure to atherogenic lipoprotein particles may be at a greater risk of ...

Dyslipidemia, marked by abnormal cholesterol and triglyceride levels, remains a major health risk in developing countries and ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepa ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

A study published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital in the Journal of Lipid Research provides new evidence on the essential ...

The result? ApoB count was the strongest and most reliable predictor of heart disease. This marker, which reflects the number ...

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll ...

Elevated lipoprotein(a) levels can slowly block the arteries, increasing the likelihood of cardiovascular disease. Since no treatment is currently available for this condition, it is essential to ...

LDL (low-density lipoprotein) cholesterol is often called the “bad” cholesterol because it collects in the walls of your blood vessels, raising your chances of health problems. Learn more ...

Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. But to influencers on TikTok, ...

CHICAGO — Lipoprotein(a) is a risk factor for cardiovascular disease you may not hear about in your annual physical. Like LDL, or “bad” cholesterol, too much of the LDL-like particle can ...